OBJECTIVES: Heart transplantation represents the most effective therapy that is currently available for end-stage heart failure. Despite the shortage of organ donors, many donor hearts are not accepted for transplantation due to poor function. Targeted donor management may increase the donor heart utilization rate. The aim of this study is to analyse a 2-year experience of early donor management through the 'scout programme' by a high-volume national cardiothoracic organ retrieval team.
INTRODUCTION
Fifty years after the first clinical case was carried out, heart transplantation remains the most effective therapy for advanced heart failure refractory to medical treatment with excellent long-term outcomes [1] . To date, the most important factor limiting heart transplantation continues to be a shortage of donor organs. Recent data revealed that over 40% of patients listed for heart transplantation in the UK have not received a transplant even after being listed for 3 years. This is mainly due to the prolonged waiting time for a suitable donor heart, leading to clinical deterioration or death [2] .
The increasing demand for more donor hearts has driven the need to extend donor heart acceptance criteria to maintain the utilization rate from the existing donor pool. Conventional acceptance thresholds, including donor age, ischaemic time, left ventricular hypertrophy, episodes of cardiac arrest, systemic infection and weight mismatch, have all been relaxed [3] . Despite this approach, which enables some of the more marginal donor hearts to be accepted, only a fraction of all donor hearts are actually retrieved and transplanted due to worsening donor profiles. Khush et al. [4] reported that only 32% of the potential heart donors in the USA become actual donors. In the UK, the situation is worse with only 27% of donor hearts from donation after brain death (DBD) progressing to transplantation [2] . There are a number of reasons that may account for this low utilization rate, including donor comorbidities, coronary artery disease, poor cardiac function, logistical problems and suboptimal donor management following brain stem death (BSD). Among these reasons, suboptimal donor management could potentially be addressed by a targeted approach.
The relationship between BSD and donor organ injury resulting from haemodynamic, hormonal, inflammatory and biochemical changes is well recognized [5, 6] . We propose that after the confirmation of BSD, a strategy of early donor management by the cardiothoracic retrieval team could improve donor heart function and increase the donor heart utilization rate without an increase in the incidence of primary graft dysfunction (PGD) following heart transplantation. The aim of this study was to analyse a 2-year experience of an early donor management initiative by the cardiothoracic retrieval team of the Royal Papworth Hospital.
MATERIALS AND METHODS
The 'cardiothoracic donor scout programme'
The programme of early donor management delivered by a member of the cardiothoracic retrieval team, or the 'scout programme', was initiated at the Royal Papworth Hospital in April 2013 with the aim of increasing the number and improving the quality of donor hearts retrieved and transplanted. In the UK, according to the National Organ Retrieval Service protocol, each designated donor organ retrieval service is responsible for organ retrieval within a specified geographic zone. Prior to the initiation of the 'scout programme', the retrieval team was only dispatched when all the donated organs had been allocated, and the retrieval team would meet the donor for the first time in the operating theatre of the donor hospital. The 'scout programme' involves dispatching member(s) of the cardiothoracic retrieval team to the intensive care unit (ICU) of the donor hospital as soon as the consent for organ donation has been obtained in order to facilitate the delivery of a nationally agreed Donor Optimization Extended Care Bundle [7] . The cardiothoracic donor 'scout' members bring with them all the necessary equipment and disposables to ensure consistency of the approach and to minimize resource use by the donor hospital. The 'donor scout' service is available 24 h a day, 7 days a week, and donor hospitals within our pre-defined retrieval zone are at liberty to decide whether they wished to take advantage of this service.
'Scouting' of the donors is carried out by our on-call donor care physiologists who are advanced nurse practitioners specifically trained in the delivery of advanced donor care. Their competencies include performing line placement for invasive haemodynamic monitoring, transoesophageal echocardiography, tracheal intubation, and fibre-optic bronchoscopy and the use of intravenous fluids, hormones, vasoactive drugs and inotropes.
Periodic endotracheal suctioning and lung recruitment manoeuvres are performed as required. The nationally agreed Donor Optimization Extended Care Bundle includes hormone replacement therapy as follows:
• Liothyronine, 4-mg bolus, followed by an infusion of 3 mgÁh -1 .
• Argipressin (ADH), 1-unit bolus, followed by an infusion of 1-5 UÁh Haemodynamic parameters are monitored continuously up to the time of organ procurement in the operating room. The final decision of whether the donor heart is accepted for transplantation is made by the lead retrieval surgeon in agreement with the transplanting surgeon after inspecting the heart in the operating room.
Study design
A prospective cohort study was carried out between 1 April 2013 and 31 March 2015 (Fig. 3) .
The inclusion criteria for scout attendance were as follows:
i. donor age between 16 and 65 years; ii. consent for heart donation; iii. no absolute contraindications for cardiac donation; iv. donor hospital within 2-hour road travel from the retrieval centre.
Extended donor criteria were defined as donors ) at the time the donor organs were offered [8] . PGD was defined as death due to donor heart failure or requirement for mechanical circulatory support within 24 h of the heart transplant; the exclusion criteria for PGD diagnosis included hyper-acute rejection, sepsis, right ventricular dysfunction due to pulmonary hypertension and bleeding [9] .
The study population was divided into donors who received early donor management by a scout in ICU and donors who were not attended to by a scout in the ICU. The non-scouted group included donors at hospitals that did not agree to participate in the scout programme, scout requests being received when the cardiothoracic retrieval team was already attending another donor and therefore unavailable to scout and donors at hospitals more than 2 h away by road. Non-scouted donors were managed by the ICU staff of the donor hospital according to the Donor Optimization Extended Care Bundle, same as the one used by the 'scouts'.
For non-scouted donors, protocolled interventions that had not been performed in the ICU by the donor hospital staff would be carried out by the cardiothoracic retrieval team once the donor is transferred to the operation room prior to the start of organ retrieval. A subgroup analysis was performed on extended criteria donors.
The primary outcome was the utilization rate of DBD donor hearts. Secondary outcomes included the utilization rate of extended criteria DBD donor hearts, donor preparation time in the operating room prior to skin incision, incidence of PGD following heart transplant and 30-day, 1-year and 2-year survival.
The 'donor scout' programme was authorized by the National Health Service Blood and Transplant special health authority as a pilot service to evaluate feasibility. As a result, the approval of the institutional review board was not applicable.
Statistical analysis
A descriptive analysis was performed on the 2 groups. Continuous variables were tested for normality with the Shapiro-Wilks test: normal variables were presented as mean and standard deviation, whereas non-normal variables as median and first and third quartiles. Accordingly, normal variables were compared with the Student's ttest and non-normal ones with the Wilcoxon's test for matched data and the Mann-Whitney test for independent distributions. Categorical variables were presented as frequency and percentage and compared with the v 2 test or, when appropriate (at least 1 expected value <5), with the Fisher's test. All factors with a level of significance <0.30 in the univariable analysis were considered for the multivariable logistic regression model. The results were expressed with odds ratio and with a confidence interval of 95%. The survival analysis was performed using the Kaplan-Meier freedom from death curves. A comparison was carried out using the Mantel-Cox test. All the statistical tests were 2-sided, and P-values of 0.05 or less were considered statistically significant. Statistical analyses were conducted using the SAS software package (SAS Institute, Cary, NC, USA; version 9.3) and StatPlus for Mac version 5 (AnalystSoft Inc.).
RESULTS
Between April 2013 and April 2015, 178 cardiac donors met the inclusion criteria for the 'scout programme'. One hundred and six donors (59.5%) received early donor management by the cardiothoracic retrieval 'scout', and 72 donors (40.5%) were managed by the donor hospital ICU staff prior to retrieval ('nonscouted' donors) (Fig. 3 ). There were no significant differences in donor characteristics between the 'scouted' and 'non-scouted' groups at baseline ( Table 1) .
The donors in the 'scouted' group were managed by the 'scout' in the donor hospital ICU for a mean duration of 543 ± 257 min. The donor heart utilization rate in the 'scouted' group was 47.2% (50/106 donors) compared with 30.6% (22/72 donors) in the 'non-scouted' group (P = 0.03) (Fig. 3 and Table 1 ). Causes for heart decline in each group are shown in Table 1 . Donor data of subgroups and comparison between retrieved and not-retrieved hearts are listed in Table 2 : in the scouted group, donor age and history of diabetes are significantly higher in declined hearts; in the non-scouted group, donor age, body mass index, history of hypertension and traumatic cause of death are significantly higher in declined hearts.
Based on the logistic regression analysis, 'scout' donor management, younger age and cause of death not related to hypoxic brain injury or cerebral oedema independently predicted donor heart utilization for transplantation (Table 3) .
One hundred and twenty-three of the 178 donors (69.1%) were considered extended criteria donors with 74 of the 106 donors (69.8%) in the 'scouted' group and 49 of the 72 donors (68.1%) in the 'non-scouted' group (P = 0.93). The donor heart utilization rate was higher in standard donors than in extended criteria donors: 54.5% (30/55) vs 34.1% (42/123), respectively (P = 0.02). Of the extended criteria donors, 40.5% (30/74) of donor hearts were transplanted from the 'scouted' group compared with 24.5% (12/49) from the 'non-scouted' group (P = 0.10).
There were no differences in the incidence of PGD or the 30-day, 1-year and 2-year survival rate between groups (P = 0.58, P > _ 0.99, P = 0.21 and P = 0.30, respectively; Table 4 and Fig. 4) .
The mean duration in the operating theatre from donor arrival to skin incision was significantly shorter in the 'scouted' group (63 ± 42 min) compared with the 'non-scouted' group (142 ± 64 min, P < 0.0001).
DISCUSSION
With the severe shortage of organ donors, it is imperative that every effort is made to maximize donor organ utilization. In the period leading up to the development of BSD and thereafter, the donor heart and lungs are subjected to extremes of haemodynamic, endocrine, inflammatory and pharmacological stresses. Not infrequently, these result in donor organ dysfunction to the extent that jeopardizes their acceptability for transplantation. Conventionally, organ donors are managed by the ICU staff at donor hospitals. Whilst the care of ICU patients must always be focused on optimizing patient outcome, once BSD has been confirmed and consent for organ donation has been obtained, care should be refocused on maximizing the quality and the number of organs donated and transplanted. Whilst some ICU teams are particularly skilled at delivering donor care, the majority of hospitals take care of <5 multiorgan donors every year. This means that their staff may have limited opportunity to develop the experience and expertise required to deliver optimal donor care, and donors with confirmed BSD are less likely to receive the specialist attention that they require. Invasive haemodynamic monitoring is frequently incomplete or unavailable. At times, limited attention is paid to the volume status of the donors. As a result, arterial hypotension is often empirically treated with norepinephrine infusion irrespective of the cause, which can contribute to donor heart dysfunction [10] [11] [12] .
Our cardiothoracic organ retrieval service had been offering an educational programme on donor management for ICU staff at our regional hospitals for the past 25 years. Despite this effort, there has been little change in the way that organ donors are managed. In fact, we saw a continued decline in the number and the quality of donors over that period, and the utilization rate of DBD hearts in the UK has stubbornly remained below 25% throughout the last decade. In some European countries, the utilization rate of DBD hearts has even decreased to below 20%.
The cardiothoracic transplant community has long been aware of the variability of donor care at different hospitals. Adoption of a standardized and focused approach to donor management by cardiothoracic retrieval teams in the operating room immediately prior to organ retrieval has been shown to improve donor heart function and their utilization [13] . Staff who regularly manage multiorgan donors are more likely to deliver consistent donor management and maintain this expertise. However, once the donor has been transferred to the operating room, the pressure to proceed with the retrieval operation often curtails opportunities for comprehensive donor care. This is the rationale for deploying members of the cardiothoracic retrieval team to initiate donor optimization earlier in the ICU as soon as the consent for organ donation has been obtained.
After extensive consultation between cardiothoracic retrieval services and intensive care professionals, a nationally agreed Donor Optimization Extended Care Bundle was issued in the UK in 2013 [7] . With the support of the specialist health authority of An independent anonymous survey of donor hospital staff who had first-hand experience of working alongside scouts was carried out in 2015, and feedback from the organ donation professionals including intensive care physicians, clinical leads for organ donation and specialist nurses for organ donation has been very positive. This study demonstrated that a designated regional cardiothoracic organ retrieval service is able to provide trained member(s) of the staff to ICUs of the donor hospital to facilitate donor optimization on a 24 h a day, 7 days a week basis. In the majority of cases, this provided a 6-to 10-h head start for comprehensive donor assessment and targeted donor optimization.
Donor heart utilization increased from 30.6% in 'non-scouted' donors to 47.2% in 'scouted' donors, which represented a 54% increase. Much of this increase was accounted for by a reduction in donor heart decline due to poor function from 26.4% in 'nonscouted' donors to 12.3% in 'scouted' donors. This suggests that a substantial proportion of donor hearts with poor function can be reconditioned and transplanted with earlier and a longer period of donor optimization. The results support the hypothesis that earlier donor management delivered by a member of the cardiothoracic retrieval team in the donor ICU can increase the donor heart utilization rate. Moreover, younger age and the cause of death not related to hypoxic brain injury or cerebral oedema independently predicted donor heart utilization. The significantly increased donor heart utilization rate from scouted donors did not result in inferior recipient survival at 1 and 2 years posttransplant. This suggests that this higher donor heart utilization was not achieved by simply accepting and transplanting suboptimal hearts from 'scouted' donors.
Of the 178 DBD donors included in this study, 72 donor hearts were eventually accepted and transplanted, constituting a donor heart utilization rate of 40.4% for the whole cohort. Prior to this scout initiative, the donor heart utilization rate in the UK had been <25% in any given year over the previous decade. Therefore, it appears that the scout initiative was associated with a significantly higher donor heart utilization rate.
Some previous studies and reviews had reported a limited efficacy of early interventions on DBD donors [14, 15] . The negative findings from these studies largely refer to the effect of hormone replacement therapy administration, whilst our protocol involves a comprehensive package of donor assessment and donor management. Moreover, our protocol differed from Wood et al.'s [16] algorithm in which hormone replacement therapy and advance invasive monitoring were only implemented in cases of left ventricle impairment and haemodynamic instability.
In the current study, there were 123 extended criteria donors accounting for 69.1% of all cardiac donors within this study period. Amongst these donors, 40.5% of donor hearts were transplanted in the scouted group compared with 24.5% in the nonscouted group. This finding is in line with a smaller study on 26 extended criteria donors in which early donor management in the ICU delivered by the retrieval team resulted in an even higher donor heart utilization rate of 56% [17] .
Another aspect that was investigated in this study was the time spent on donor preparation in the operating room from donor arrival to skin incision. In donors who were not attended to by a 'scout' in the ICU, invasive monitoring lines, fibre-optic bronchoscopy and transoesophageal echocardiography assessment had to be carried out in the operating room, thus holding up the start of the retrieval operation. In the 'scouted' setting, donors had already been fully instrumented and assessed in the ICU, and no delay to retrieval was necessary once the donor arrived in the operating room. The donor preparation time was therefore reduced from 142 min in 'non-scouted' donors to 62 min in 'scouted' donors, which was a saving of 79 min. This is viewed as a positive development by donor hospital administrators because it means that the duration that an emergency operating room being occupied by the retrieval procedure is significantly reduced, thus minimizing disruption to regular theatre activity at the donor hospital.
Limitations
The retrospective, non-blinded and single-centre design and the relatively small sample size are the main limitations of the study. The definition of PGD is the one used by the National Health Service Blood and Transplant Cardiothoracic Transplant Advisory Audit Group and is different from the one proposed by ISHLT. Moreover, the actual interventions carried out on the donors, particularly haemodynamic changes, when the retrieval team was deployed and the recipients' early outcomes were not systematically documented. However, this is a description of the actual experience and the service evaluation of implementing a novel approach to the process of donor management within the complex pathway of multiorgan donors involving numerous teams, and the primary end point of the present study is the donor heart utilization rate. Early donor management by scouts is undoubtedly resource intensive and incurred extra expenditure. However, our cardiothoracic organ retrieval team is already on call 24 h a day, 7 days a week for donor organ retrieval; therefore, scouting simply makes more effective use of the on-call retrieval team. Other factors that offset the added cost of scouting include the following: (i) the scouts only travelled to donor hospitals by an ordinary taxi (£300 per scouted donor) as opposed to the whole retrieval team who would be transported by a specially contracted vehicle driven by a qualified ambulance driver (£1000 per donor). For donors who were eventually declined by all UK centres after scouting, attendance by the scout saved the rest of the retrieval team travelling to the donor hospital by the special vehicle, thus resulting in significant cost savings on the more expensive form of transport. The total cost for all scout transport by taxi during the study period was £30 444. During the study period, there were 39 scouted donors who were not subsequently attended to by the whole retrieval team because all the cardiothoracic organs were declined after scouting. The estimated special transport cost saving was in excess of £39 000. Therefore, it appears that the estimated cost savings on avoiding team transport more than offset the taxi cost for the scouts during the study. (ii) By completing donor assessment in the ICU before the donor is transferred to the operating room, 1.5 h of operating room time per donor were saved; and (iii) while scouting on ICU, vascular catheters, drugs and fluids are used with an average cost of £500 per donor. However, using these disposables during scouting means that the retrieval team can continue to use them in the operating theatre during the retrieval operation, instead of using fresh ones. Therefore, for donors who proceeded to the operating room for sternotomy, the disposables used during scouting would have been cost-neutral. An excess cost would only have been incurred in donors who were scouted but not subsequently attended to by the rest of the retrieval team because all the cardiothoracic organs were declined. As stated earlier, there were 39 such donors and the estimated excess disposable cost for them would have amounted to £19 500. As our scouts were already paid to be on-call for donor organ retrieval and the cost savings for the retrieval team transport more than offset the taxi cost for the scouts, the cost of extra disposables used during the scout programme was effectively the only additional cost to the NHS Blood and Transplant.
Finally, there are many factors that can affect the consent rate for organ donation and donor organ utilization rate. These can include socio-economical, cultural, political, religious and healthcare system factors. Whilst early donor management in the ICUs of donor hospitals as described in this study appeared to have a positive impact on donor heart utilization in the UK, it may not be directly translatable to healthcare systems in other countries.
CONCLUSIONS
Early donor management according to a nationally agreed protocol can be initiated by members of the cardiothoracic retrieval team in the ICUs of donor hospitals soon after obtaining the consent for organ donation. This can proceed in parallel with donor organ allocation and waiting-for-organ offers to be accepted. Such an approach provides a 6-10 h head start for donor optimization and significantly increases the donor heart utilization rate when compared with using the same care package just prior to organ retrieval in the operating room. Adopting such an approach could increase the donor heart utilization rate from the current donor pool.
